Cardiac Computed Tomography (CT) Scan Compared to Transesophageal Echocardiogram (TEE) in Endocarditis

This study has been terminated.
(Difficult recruitment)
Sponsor:
Information provided by (Responsible Party):
Lihua QU, William Beaumont Hospitals
ClinicalTrials.gov Identifier:
NCT00995384
First received: October 14, 2009
Last updated: March 21, 2012
Last verified: March 2012
  Purpose

The purpose of this study is to assess the effectiveness of cardiac CT versus TEE in endocarditis patients.


Condition Intervention
Endocarditis
Procedure: CT Scan

Study Type: Interventional
Study Design: Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Diagnostic
Official Title: A Novel Modality of Cardiac CT in Characterization of Acute Infective Endocarditis

Resource links provided by NLM:


Further study details as provided by William Beaumont Hospitals:

Primary Outcome Measures:
  • Visual Difference in CT versus TEE images in Endocarditis [ Time Frame: Upon CT Scan ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Morbidity [ Time Frame: 4 weeks & 6 months post CT scan ] [ Designated as safety issue: No ]

Enrollment: 2
Study Start Date: October 2009
Study Completion Date: October 2010
Primary Completion Date: October 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
CT scan
CT Scan for endocarditis patients. All patients receive intervention.
Procedure: CT Scan
Cardiac CT with special attention to valves in Endocarditis patients.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Acute endocarditis with positive TEE

Exclusion Criteria:

  • Renal failure
  • Contrast dye allergy
  • Beta-blocker allergy
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00995384

Locations
United States, Michigan
William Beaumont Hosptial
Royal Oak, Michigan, United States, 48073
Sponsors and Collaborators
William Beaumont Hospitals
Investigators
Principal Investigator: Phillip Kadaj, MD William Beaumont Hospitals
  More Information

No publications provided

Responsible Party: Lihua QU, Coordinator, William Beaumont Hospitals
ClinicalTrials.gov Identifier: NCT00995384     History of Changes
Other Study ID Numbers: HIC 2009-148, R/C# 98699, RI-09-17
Study First Received: October 14, 2009
Last Updated: March 21, 2012
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Endocarditis
Heart Diseases
Cardiovascular Diseases

ClinicalTrials.gov processed this record on August 21, 2014